Terms: = Endocrine gland cancer AND PAX8, ENSG00000125618, 7849 AND Prognosis
71 results:
1. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
2. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
[TBL] [Abstract] [Full Text] [Related]
3. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical characteristics of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report and review.
Guo H; Zhang Z; Huang C; Qiu J; Qu X
Medicine (Baltimore); 2023 Jan; 102(4):e32655. PubMed ID: 36705380
[TBL] [Abstract] [Full Text] [Related]
5. Papillary Thyroid Carcinoma With Squamous Dedifferentiation: A Potential Diagnostic Pitfall.
Ijaz K; Yin F
Anticancer Res; 2023 Jan; 43(1):255-258. PubMed ID: 36585182
[TBL] [Abstract] [Full Text] [Related]
6. Construction and Characterization of Cadherin 6 (CDH6)-Targeting Chimeric Antigen Receptor (CAR) Modified T Cells.
Pang L; Ren F; Xu X; Fu L; Wang T; Guo Z
J Environ Pathol Toxicol Oncol; 2022; 41(1):55-71. PubMed ID: 35378004
[TBL] [Abstract] [Full Text] [Related]
7. pax8 and MECOM are interaction partners driving ovarian cancer.
Bleu M; Mermet-Meillon F; Apfel V; Barys L; Holzer L; Bachmann Salvy M; Lopes R; Amorim Monteiro Barbosa I; Delmas C; Hinniger A; Chau S; Kaufmann M; Haenni S; Berneiser K; Wahle M; Moravec I; Vissières A; Poetsch T; Ahrné E; Carte N; Voshol J; Bechter E; Hamon J; Meyerhofer M; Erdmann D; Fischer M; Stachyra T; Freuler F; Gutmann S; Fernández C; Schmelzle T; Naumann U; Roma G; Lawrenson K; Nieto-Oberhuber C; Cobos-Correa A; Ferretti S; Schübeler D; Galli GG
Nat Commun; 2021 Apr; 12(1):2442. PubMed ID: 33903593
[TBL] [Abstract] [Full Text] [Related]
8. A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer.
Lo Riso P; Villa CE; Gasparoni G; Vingiani A; Luongo R; Manfredi A; Jungmann A; Bertolotti A; Borgo F; Garbi A; Lupia M; Laise P; Das V; Pruneri G; Viale G; Colombo N; Manzo T; Nezi L; Cavallaro U; Cacchiarelli D; Walter J; Testa G
Genome Med; 2020 Oct; 12(1):94. PubMed ID: 33121525
[TBL] [Abstract] [Full Text] [Related]
9. Identification of an immune-related key gene, PPARGC1A, in the development of anaplastic thyroid carcinoma: in-silico study and in-vitro evaluation.
Huang Y; Ling J; Chang A; Ye H; Zhao H; Zhuo X
Minerva Endocrinol (Torino); 2022 Jun; 47(2):150-159. PubMed ID: 32720497
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.
Bardet S; Goardon N; Lequesne J; Vaur D; Ciappuccini R; Leconte A; Monpeyssen H; Saguet-Rysanek V; Clarisse B; Lasne-Cardon A; Ménégaux F; Leenhardt L; Buffet C
Endocrine; 2021 Feb; 71(2):407-417. PubMed ID: 32638211
[TBL] [Abstract] [Full Text] [Related]
11. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
12. Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma.
De Thaye E; Van de Vijver K; Van der Meulen J; Taminau J; Wagemans G; Denys H; Van Dorpe J; Berx G; Ceelen W; Van Bocxlaer J; De Wever O
Sci Rep; 2020 Apr; 10(1):6688. PubMed ID: 32317693
[TBL] [Abstract] [Full Text] [Related]
13. prognosis Based Definition of Resectability in Pancreatic cancer: A Road Map to New Guidelines.
Oba A; Croce C; Hosokawa P; Meguid C; Torphy RJ; Al-Musawi MH; Ahrendt S; Gleisner A; Schulick RD; Del Chiaro M
Ann Surg; 2022 Jan; 275(1):175-181. PubMed ID: 32149822
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
[TBL] [Abstract] [Full Text] [Related]
15. Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics.
Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Höög A; Juhlin CC
Diagn Pathol; 2019 Nov; 14(1):127. PubMed ID: 31699114
[TBL] [Abstract] [Full Text] [Related]
16. Emerging Roles of GLI-Similar Krüppel-like Zinc Finger Transcription Factors in Leukemia and Other cancers.
Jetten AM
Trends Cancer; 2019 Sep; 5(9):547-557. PubMed ID: 31474360
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
[No Abstract] [Full Text] [Related]
18. ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma.
Bi R; Bai Q; Zhu X; Tu X; Cai X; Jiang W; Xu X; Tang S; Ge H; Chang B; Cheng Y; Gan H; Zhou X; Yang W
Diagn Pathol; 2019 Aug; 14(1):96. PubMed ID: 31455365
[TBL] [Abstract] [Full Text] [Related]
19. Coding Molecular Determinants of Thyroid cancer Development and Progression.
Valvo V; Nucera C
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):37-59. PubMed ID: 30717910
[TBL] [Abstract] [Full Text] [Related]
20. Metastasis to Stomach in a Patient with Anaplastic Thyroid Carcinoma: A Clinical Challenge.
Fuladi R; Nagarkar R; Roy S
Am J Case Rep; 2019 Feb; 20():134-138. PubMed ID: 30705249
[TBL] [Abstract] [Full Text] [Related]
[Next]
